论文部分内容阅读
目的 :探究阿奇霉素序贯疗法治疗小儿支原体肺炎效果。方法 :随机选取本院2015年3月至2016年5月40例小儿支原体肺炎患儿作为研究对象,所有患者的临床表现为咳嗽、胸闷等,并伴有呼吸啰音,均符合小儿支原体肺炎诊断标准。根据随机分配原则,将40例患者分为对照组和观察组,每组各20例。两组患儿在年龄、性别、病程等一般资料方面比较,差异不具有统计学意义,P>0.05,因此具有可比性。对于对照组患儿,采用阿奇霉素连续用药法进行治疗。对于观察组患儿,采用阿奇霉素序贯疗法进行治疗。对两组患儿疗效进行比较分析。结果 :观察组患儿临床总有效率为95.0%,对照组患儿临床总有效率为80.0%。观察组患儿的不良反应率为25.0%,对照组患儿的不良反应率为15.0%。组间比较差异具有统计学意义,P<0.05。结论:在对小儿支原体肺炎患儿进行治疗时,采用阿奇霉素序贯疗法进行治疗,治疗有效率比较高,而且不良反应发生率比较低,疗效安全显著,值得推广和应用。
Objective: To investigate the effect of sequential treatment of azithromycin on mycoplasma pneumonia in children. Methods: A total of 40 children with mycoplasma pneumonia from March 2015 to May 2016 in our hospital were randomly selected. The clinical manifestations of all patients were cough, chest tightness and so on, accompanied by respiratory ailments, which were all in line with the diagnosis of mycoplasma pneumonia in children standard. According to the principle of random distribution, 40 patients were divided into control group and observation group, 20 cases in each group. Two groups of children in terms of age, gender, duration and other general information, the difference was not statistically significant, P> 0.05, it is comparable. For children in the control group, azithromycin was used for continuous treatment. For the observation group of children, treatment with azithromycin sequential therapy. The efficacy of the two groups of children were analyzed comparatively. Results: The total clinical effective rate was 95.0% in the observation group and 80.0% in the control group. Adverse reaction rate was 25.0% in the observation group and 15.0% in the control group. The difference between the groups was statistically significant, P <0.05. Conclusion: In the treatment of pediatric children with mycoplasma pneumonia, azithromycin sequential therapy for treatment, the treatment is relatively efficient, and the incidence of adverse reactions is relatively low, the safety of the significant effect, it is worth promoting and application.